Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study

被引:41
|
作者
Gordon, Nancy P. [1 ]
Green, Beverly B. [2 ]
机构
[1] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA
[2] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA
关键词
CRC; Colorectal cancer screening; Fecal immunochemical test; Patient attitudes; OCCULT BLOOD-TESTS; PARTICIPATION; ADHERENCE; CARE;
D O I
10.1186/s12889-015-1908-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The one-sample fecal immunochemical test (FIT) is gaining popularity for colorectal cancer (CRC) screening of average-risk people. However, uptake and annual use remain suboptimal. Methods: In 2013, we mailed questionnaires to three groups of nonHispanic White, Black, and Latino Kaiser Permanente Northern California (KPNC) members ages 52-76 who received FIT kits in 2010-2012: Continuers did the FIT all 3 years; Converts in 2012, but not 2010 or 2011; and Nonusers in none of the 3 years. The questionnaires covered social influences, perceived CRC risk, reasons for using (Continuers, Converts) or avoiding using (Nonusers) the FIT, and recommendations for improving the kit. Results: Continuers (n = 607, response rate 67.5 %), Converts (n = 317, response rate 35.6 %), and Nonusers (n = 215, response rate 21.1 %) did not differ in perceived risk or family history of CRC, but Nonusers were less likely than Continuers and Converts to know someone who had polyps or CRC. Continuers, Converts, and Nonusers did not differ in social network encouragement of CRC screening, but did differ in believing that it was very important that they be screened (88.3 %, 68.4 %, 47.7 %) and that their medical team thought it very important that they be screened (88.6 %, 79.9 %, 53.9 %). Approximately half of Continuers and Converts completed the FIT to please their doctor. Converts were less likely than Continuers to use the FIT to "make sure they were OK" (53.7 % vs. 72.6 %) or "protect their health" (46.1 % vs. 76.4 %). Nearly half of Converts completed the FIT out of guilt. Approximately half of FIT kit users suggested adding a disposable glove, extra paper, and wider-mouth tube to the kit. Nonusers' reasons for not using the FIT included discomfort, disgust, or embarrassment (59.6 %); thinking it unnecessary (32.9 %); fatalism/fear (15.5 %); and thinking it too difficult to use (14.5 %), but < 10 % did not want CRC screening at all. Conclusions: Nonusers and irregular users of the FIT are less intrinsically motivated to get CRC screening than long-term users and more averse to preparing their stool sample. Changes to the FIT kit to address discomfort and difficulty factors might improve uptake and continued use.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study
    Nancy P. Gordon
    Beverly B. Green
    [J]. BMC Public Health, 15
  • [2] Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs
    Vivy T. Cusumano
    Folasade P. May
    [J]. Journal of General Internal Medicine, 2020, 35 : 1870 - 1874
  • [3] Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs
    Cusumano, Vivy T.
    May, Folasade P.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (06) : 1870 - 1874
  • [4] Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population
    Ramai, Daryl
    Etienne, Denzil
    Ayide, Gloria
    Fields, Paul J.
    Reddy, Madhavi
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (10) : 744 - 749
  • [5] Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach
    Lee, Briton
    Keyes, Erin
    Rachocki, Carly
    Grimes, Barbara
    Chen, Ellen
    Vittinghoff, Eric
    Ladabaum, Uri
    Somsouk, Ma
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : 1326 - +
  • [6] Screening for Colorectal Cancer in Taiwan and France: Does the Fecal Immunochemical Test (FIT) Fit?
    Braillon, Alain
    [J]. CANCER, 2015, 121 (24) : 4441 - 4442
  • [7] Comparison of Outreach and Inreach Approaches in a Nationwide Colorectal Cancer Screening Program Using the Fecal Immunochemical Test
    Lee, Yi-Chia
    Chiu, Han-Mo
    Chou, Chu-Kuang
    Wu, Ming-Shiang
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S784 - S784
  • [8] Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening
    Chen, Juan
    Lin, Jie
    Zhang, Lijing
    Chen, Mengshi
    Yu, Xunbin
    Wu, Yijuan
    Wang, Tao
    Xu, Rongrong
    Tian, Tian
    Sun, Aijuan
    Zhang, Tiantian
    Lu, Yan
    Ba, Zhaofen
    Cheng, Xiaowei
    Chen, Minghong
    [J]. CLINICAL LABORATORY, 2022, : 2446 - 2453
  • [9] Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening
    Chen, Juan
    Lin, Jie
    Zhang, Lijing
    Chen, Mengshi
    Yu, Xunbin
    Wu, Yijuan
    Wang, Tao
    Xu, Rongrong
    Tian, Tian
    Sun, Aijuan
    Zhang, Tiantian
    Lu, Yan
    Ba, Zhaofen
    Cheng, Xiaowei
    Chen, Minghong
    [J]. CLINICAL LABORATORY, 2022, 68 (12) : 2446 - 2453
  • [10] Adherence to Colorectal Cancer Screening: 4 Rounds of Fecal Immunochemical Test (FIT) Based Screening
    van der Vlugt, Manon
    Grobbee, Esmee J.
    Kuipers, Ernst J.
    Lansdorp-Vogelaar, Iris
    Essink-Bot, Marie-Louise
    Bossuyt, Patrick
    Spaander, Manon
    Dekker, Evelien
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S755 - S755